Cellectar Biosciences
CLRB
CLRB
20 hedge funds and large institutions have $3.08M invested in Cellectar Biosciences in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$60K | |
| 2 | +$12.9K | |
| 3 | +$11.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$528 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$96 |
Top Sellers
| 1 | -$231K | |
| 2 | -$45K | |
| 3 | -$17.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.84K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |